Stay updated on Immunotherapy with TIL in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy with TIL in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy with TIL in Metastatic Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Maryland is now listed as a location under the Locations section, updating the trial's geographic availability. The Maryland Locations subsection and the HHS Vulnerability Disclosure link were removed as part of revision v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T09:00:43.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Site revision updated from v3.3.1 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-12-01T17:14:33.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T14:33:13.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The government funding lapse notice and operating status banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:39:19.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    Only cosmetic/UI updates were observed. No changes to core study content, eligibility criteria, or outcomes were detected.
    Difference
    0.3%
    Check dated 2025-11-03T01:14:14.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    The page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T10:13:44.000Z thumbnail image

Stay in the know with updates to Immunotherapy with TIL in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy with TIL in Metastatic Melanoma Clinical Trial page.